|
1
|
Ray K: Liver: Hepatic stellate cells hold
the key to liver fibrosis. Nat Rev Gastroenterol Hepatol.
11:742014. View Article : Google Scholar
|
|
2
|
Kocabayoglu P and Friedman SL: Cellular
basis of hepatic fibrosis and its role in inflammation and cancer.
Front Biosci (Schol Ed). 5:217–230. 2013.
|
|
3
|
Mello T, Ceni E, Surrenti C and Galli A:
Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects
Med. 29:17–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jian YC, Li W, He Y, Jiang M, Liu YB and
Xiong WJ: Effect of oxymatrine on hepatic gene expression profile
in experimental liver fibrosis of rats. Chin J Integr Med.
18:445–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parise ER, de Oliveira AC, Conceicao RD,
Amaral AC and Leite K: Response to treatment with interferon-alpha
and ribavirin in patients with chronic Hepatitis C virus genotypes
2 and 3 depends on the degree of hepatic fibrosis. Braz J Infect
Dis. 10:78–81. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsolaki E, Athanasiou E, Gounari E, Zogas
N, Siotou E, Yiangou M, Anagnostopoulos A and Yannaki E:
Hematopoietic stem cells and liver regeneration: differentially
acting hematopoietic stem cell mobilization agents reverse induced
chronic liver injury. Blood Cells Mol Dis. 53:124–132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trebicka J, Hennenberg M, Odenthal M, et
al: Atorvastatin attenuates hepatic fibrosis in rats after bile
duct ligation via decreased turnover of hepatic stellate cells. J
Hepatol. 53:702–712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elsharkawy AM, Oakley F and Mann DA: The
role and regulation of hepatic stellate cell apoptosis in reversal
of liver fibrosis. Apoptosis. 10:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moreira RK: Hepatic stellate cells and
liver fibrosis. Arch Pathol Lab Med. 131:1728–1734. 2007.PubMed/NCBI
|
|
10
|
Huang Q, Huang R, Zhang S, et al:
Protective effect of genistein isolated from Hydrocotyle
sibthorpioides on hepatic injury and fibrosis induced by chronic
alcohol in rats. Toxicol Lett. 217:102–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su LJ, Chang CC, Yang CH, et al:
Graptopetalum paraguayense ameliorates chemical-induced rat hepatic
fibrosis in vivo and inactivates stellate cells and Kupffer cells
in vitro. PLoS One. 8:e539882013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu MY, Hu JJ, Shen J, Wang ML, Zhang QQ,
Qu Y and Lu LG: Stat3 signaling activation crosslinking of TGF-β1
in hepatic stellate cell exacerbates liver injury and fibrosis.
Biochim Biophys Acta. 1842.2237–2245. 2014.
|
|
13
|
Lang Q, Liu Q, Xu N, et al: The
antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats.
Biochem Biophys Res Commun. 409:448–453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen BL, Peng J, Li QF, Yang M, Wang Y and
Chen W: Exogenous bone morphogenetic protein-7 reduces hepatic
fibrosis in Schistosoma japonicum-infected mice via transforming
growth factor-beta/Smad signaling. World J Gastroenterol.
19:1405–1415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee JH, Lee H, Joung YK, et al: The use of
low molecular weight heparin-pluronic nanogels to impede liver
fibrosis by inhibition the TGF-β/Smad signaling pathway.
Biomaterials. 32:1438–1445. 2011. View Article : Google Scholar
|
|
16
|
Hang W, Li L, Tian X, Yan J, Yang X, Wang
X, Liao G1 and Qiu G: Astragalus and Paeoniae radix rubra extract
inhibits liver fibrosis by modulating the transforming growth
factor-β/Smad pathway in rats. Mol Med Rep. Nov 5–2014.(Epub ahead
of print). View Article : Google Scholar
|
|
17
|
Yu KZ, Liu J, Guo BL, et al: Microscopic
research on a multi-source traditional Chinese medicine, Astragali
Radix. J Nat Med. 68:340–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yusufoglu HS, Alam A, Zaghloul AM,
Al-Salkini MA and Alam P: Comparative anti-inflammatory and
hepatoprotective activities of astragalus gummifer labill herb and
roots in rats. Afr J Tradit Complement Altern Med. 11:268–274.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang J, Xu F, Zhang YZ, et al: The
profiling and identification of the absorbed constituents and
metabolites of Paeoniae Radix Rubra decoction in rat plasma and
urine by the HPLC-DAD-ESI-IT-TOF-MS(n) technique: a novel strategy
for the systematic screening and identification of absorbed
constituents and metabolites from traditional Chinese medicines. J
Pharm Biomed Anal. 83:108–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Knook DL, Seffelaar AM and de Leeuw AM:
Fat-storing cells of the rat liver. Their isolation and
purification. Exp Cell Res. 139:468–471. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Majumdar M, Ratho R, Chawla Y and Singh
MP: Evaluation of antigenicity and cell mediated immunity of
hepatitis E virus patients: using non radioactive MTT assay. Indian
J Med Microbiol. 31:64–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou G, Kandala JC, Tyagi SC, Katwa LC and
Weber KT: Effects of angiotensin II and aldosterone on collagen
gene expression and protein turnover in cardiac fibroblasts. Mol
Cell Biochem. 154:171–178. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu X, Rui W, Wu C, He S, Jiang J, Zhang X
and Yang Y: Compound Astragalus and Salvia miltiorrhiza extracts
suppress hepatocarcinogenesis by modulating transforming growth
factor-β/Smad sigmaling. J Gastroenterol Hepatol. 29:1284–1291.
2014. View Article : Google Scholar
|
|
24
|
Hashiba M, Ono M, Hyogo H, et al: Glycemic
variability is an independent predictive factor for development of
hepatic fibrosis in nonalcoholic Fatty liver disease. PLoS One.
8:e761612013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hossain N, Afendy A, Stepanova M, et al:
Independent predictors of fibrosis in patients with nonalcoholic
fatty liver disease. Clin Gastroenterol Hepatol. 7:1224–1229. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Svegliati-Baroni G, Bugianesi E, Bouserhal
T, et al: Post-load insulin resistance is an independent predictor
of hepatic fibrosis in virus C chronic hepatitis and in
non-alcoholic fatty liver disease. Gut. 56:1296–1301. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kowdley KV, Belt P, Wilson LA, et al:
Serum ferritin is an independent predictor of histologic severity
and advanced fibrosis in patients with nonalcoholic fatty liver
disease. Hepatology. 55:77–85. 2012. View Article : Google Scholar
|
|
28
|
Chen HJ, Liang TM, Lee IJ, Huang YT and
Lin YL: Scutellariae radix suppresses LPS-induced liver endothelial
cell activation and inhibits hepatic stellate cell migration. J
Ethnopharmacol. 150:835–842. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katz TM, Goldberg LH and Friedman PM:
Nonablative fractional photothermolysis for the treatment of striae
rubra. Dermatol Surg. 35:1430–1433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou YX, Chen J, Li JP, Wang YL and Jin
XD: Chinese medicinal herbs in treating model rats with hepatic
fibrosis. Afr J Tradit Complement Altern Med. 7:104–108. 2010.
|
|
31
|
Vitcheva V, Simeonova R, Krasteva I,
Nikolov S and Mitcheva M: Protective effects of a purified saponin
mixture from Astragalus corniculatus Bieb., in vivo hepatotoxicity
models. Phytother Res. 27:731–736. 2013. View Article : Google Scholar
|
|
32
|
D’Argenio G, Mazzone G, Ribecco MT, et al:
Garlic extract attenuating rat liver fibrosis by inhibiting TGF-β1.
Clin Nutr. 32:252–258. 2013. View Article : Google Scholar
|
|
33
|
Li J, Li J, Li S, et al: Ameliorative
effect of grAPE seed proanthocyanidin extract on
thioacetamide-induced mouse hepatic fibrosis. Toxicol Lett.
213:353–360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lang Q, Liu Q, Xu N, et al: The
antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats.
Biochem Biophys Res Commun. 409:448–453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu X, Yang Y, Zhang X, et al: Compound
Astragalus and Salvia miltiorrhiza extract inhibits cell invasion
by modulating transforming growth factor-beta/Smad in HepG2 cell. J
Gastroenterol Hepatol. 25:420–426. 2010. View Article : Google Scholar
|
|
36
|
Tian XP, Yin YY and Li X: Effects and
mechanisms of Acremoniumterricola milleretal mycelium on liver
fibrosis induced by carbon tetrachloride in rats. Am J Chin Med.
39:537–550. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cai Y, Zhou CH, Fu D and Shen XZ:
Overexpression of Smad ubiquitin regulatory factor 2 suppresses
transforming growth factor-beta mediated liver fibrosis. J Dig Dis.
13:327–334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sferra R, Vetuschi A, Catitti V, et al:
Boswellia serrata and Salvia miltiorrhiza extracts reduce
DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation.
Eur Rev Med Pharmacol Sci. 16:1484–1498. 2012.PubMed/NCBI
|
|
39
|
Freudlsperger C, Bian Y, Contag WS, et al:
TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1
and SMAD7 in a subset of head and neck cancers. Oncogene.
32:1549–1559. 2013. View Article : Google Scholar
|
|
40
|
Bian EB, Huang C, Wang H, et al:
Repression of Smad7 mediated by DNMT1 determines hepatic stellate
cell activation and liver fibrosis in rats. Toxicol Lett.
224:175–185. 2014. View Article : Google Scholar
|
|
41
|
Hamzavi J, Ehnert S, Godoy P, et al:
Disruption of the Smad7 gene enhances CCI4-dependent liver damage
and fibrogenesis in mice. J Cell Mol Med. 12:2130–2144. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dooley S, Hamzavi J, Breitkopf K, et al:
Smad7 prevents activation of hepatic stellate cells and liver
fibrosis in rats. Gastroenterology. 125:178–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ji H, Tang H, Lin H, Mao J, Gao L, Liu J
and Wu T: Rho/Rock cross-talks with transforming growth
factor-β/Smad pathway participates in lung fibroblast-myofibroblast
differentiation. Biomed Rep. 2:787–792. 2014.PubMed/NCBI
|
|
44
|
Lin Z, Jiang L, Yuan C, et al: Structural
basis for recognition of urokinase-type plasminogen activator by
plasminogen activator inhibitor-1. J Biol Chem. 286:7027–7032.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang B, Li W, Chen Y, et al: Coexpression
of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver
fibrosis. Med Sci Monit. 18:R394–R401. 2012. View Article : Google Scholar
|
|
46
|
Tang LX, He RH, Yang G, Tan JJ, Zhou L,
Meng XM, Huang XR and Lan HY: Asiatic acid inhibits liver fibrosis
by blocking TGF-beta/Smad signaling in vivo and in vitro. PLoS One.
7:e313502012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Salas AL, Montezuma TD, Farina GG,
Reyes-Esparza J and Rodriguez-Fragoso L: Genistein modifies liver
fibrosis and improves liver function by inducing uPA expression and
proteolytic activity in CCl4-treated rats. Pharmacology. 81:41–49.
2008. View Article : Google Scholar
|
|
48
|
Ghosh AK and Vaughan DE: PAI-1 in tissue
fibrosis. J Cell Physiol. 227:493–507. 2012. View Article : Google Scholar
|
|
49
|
Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni
ME and Laug WE: Elevated levels of plasminogen activator
inhibitor-1 may account for the altered fibrinolysis by keloid
fibroblasts. J Invest Dermatol. 106:1007–1011. 1996. View Article : Google Scholar : PubMed/NCBI
|
